The archive

137 stories from 60 issues. Filter by industry, type of news, date or company, and choose how much to read.

1 story

Clear filters
  1. 21 OctNew

    Funding

    OpenAI buys Orchestra Bio to bring AI into drug development work

    Why it matters Biopharma teams now have OpenAI heading into their R&D operations, so reassess any AI workflow vendors you rely on.

    Impact Drug developers gain OpenAI-run AI for R&D operations, competing with existing workflow vendors.

    What happened OpenAI is buying Orchestra Bio, a company that applies AI to the day-to-day running of research and development in the life sciences. The aim is to help drug makers move treatments through development faster.